Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("SITE REACTION")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 23 of 23

  • Page / 1
Export

Selection :

  • and

DIRECT IODINATION OF SPECIFIC RESIDUES IN CRYSTALS OF YEAST FORMYLATABLE METHIONINE-ACCEPTING TRANSFER RIBONUCLEIC ACIDTROPP J; SIGLER PB.1979; BIOCHEMISTRY; USA; DA. 1979; VOL. 18; NO 24; PP. 5489-5495; BIBL. 1 P.Article

AUGMENTED LOCAL ANAPHYLAXIS AT SITES OF DELAYED HYPERSENSITIVITY SKIN REACTIONS.PEARSON DJ; TAYLOR G.1977; IMMUNOLOGY; G.B.; DA. 1977; VOL. 33; NO 1; PP. 115-119; BIBL. 13 REF.Article

ALKYLATION DE L'ADN A L'INTERIEUR DES COMPLEXES COMPLEMENTAIRES AVEC L'OLIGONUCLEOTIDE (N-CHLORO 2-ETHYL-N-METHYLAMINO) BENZYL-4 PHOSPHAMIDE-5'GIMAUTDINOVA OI; KARPOVA GG; LOMAKINA TS et al.1980; BIOORG. KHIM.; SUN; DA. 1980; VOL. 6; NO 1; PP. 70-80; ABS. ENG; BIBL. 20 REF.Article

STRUCTURAL CHARACTERIZATION BY NUCLEAR MAGNETIC RESONANCE OF A REACTIVE-SITE 13CARBON-LABELLED BASIC PANCREATIC TRYPSIN INHIBITOR WITH THE PEPTIDE BOND ARG-39-ALA-40 CLEAVED AND ARG-39 REMOVEDRICHARZ R; TSCHESCHE H; WUETHRICH et al.1979; EUROP. J. BIOCHEM.; DEU; DA. 1979; VOL. 102; NO 2; PP. 563-571; BIBL. 39 REF.Article

EFFECT OF A MOLECULAR DIPOLE ON THE IONIC STRENGTH DEPENDENCE OF A BIMOLECULAR RATE CONSTANT: IDENTIFICATION OF THE SITE OF REACTIONKOPPENOL WH.1980; BIOPHYS. J.; USA; DA. 1980; VOL. 29; NO 3; PP. 493-507; BIBL. 61 REF.Article

Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4―6 years oldQUINN, Patrick; GOLD, Michael; ROYLE, Jenny et al.Vaccine. 2011, Vol 29, Num 25, pp 4230-4237, issn 0264-410X, 8 p.Article

Determination of reaction site charge on plastocyanin from the cyanobacterium Anabaena variabilis based on electrostatic interactions with small inorganic complexesMØLAGER CHRISTENSEN, H; CONRAD, L. SP; ULSTRUP, J et al.Acta chemica scandinavica (Copenhagen. 1989). 1992, Vol 46, Num 6, pp 508-514, issn 0904-213XArticle

Lack of Genetic Association Between Exaggerated Placental Site Reaction and Placental Site Trophoblastic TumorJORGE, Dotto; PEI HUI.International journal of gynecological pathology. 2008, Vol 27, Num 4, pp 562-567, issn 0277-1691, 6 p.Article

Enfuvirtide plasma levels and injection site reactions using a needle-free gas-powered injection system (Biojector)HARRIS, Marianne; JOY, Ruth; LARSEN, Gerene et al.AIDS (London). 2006, Vol 20, Num 5, pp 719-723, issn 0269-9370, 5 p.Article

Location of xylanase and mannanase action in kraft fibresSUURNÄKKI, A; HEIJNESSON, A; BUCHERT, J et al.Journal of pulp and paper science. 1996, Vol 22, Num 3, pp J78-J83, issn 0826-6220Article

High incidence and severity of injection site reactions in the first cycle compared with subsequent cycles of subcutaneous bortezomibKAMIMURA, Tomohiko; MIYAMOTO, Toshihiro; YOKOTA, Noriko et al.International journal of hematology. 2013, Vol 98, Num 6, pp 694-701, issn 0925-5710, 8 p.Article

Enfuvirtide injection site reactions: A clinical and histopathological appraisalWALLACE, Brian J; TAN, King-Bing; PETT, Sarah L et al.Australasian journal of dermatology. 2011, Vol 52, Num 1, pp 19-26, issn 0004-8380, 8 p.Article

Safety and immunogenicity of a new formulation of interferon p-1a (Rebif® New Formulation) in a Phase Illb study in patients with relapsing multiple sclerosis : 96-week resultsGIOVANNONI, G; BARBARASH, O; CASSET-SEMANAZ, F et al.Multiple sclerosis. 2009, Vol 15, Num 2, pp 219-228, issn 1352-4585, 10 p.Article

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1bBAUM, K; O'LEARY, C; CARET FERRER, F et al.Multiple sclerosis. 2007, Vol 13, Num 9, pp 1153-1160, issn 1352-4585, 8 p.Article

Study of local oxidaitive degradation in polypropylene impact copolymer by energy dispersive X-ray systemMANABE, Norio; YOKOTA, Yoshimitsu; NAKATANI, Hisayuki et al.Polymer bulletin (Berlin. Print). 2005, Vol 54, Num 1-2, pp 141-145, issn 0170-0839, 5 p.Article

Exaggerated placental site reaction mimicking choriocarcinomaNIGAM, Sonu; DASS, Renu.Acta obstetricia et gynecologica Scandinavica. 2003, Vol 82, Num 6, pp 587-588, issn 0001-6349, 2 p.Article

Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-β-cyclodextrin following subcutaneous injection in sheepZIMEI WU; TUCKER, Ian G; RAZZAK, Majid et al.International journal of pharmaceutics (Print). 2010, Vol 397, Num 1-2, pp 96-102, issn 0378-5173, 7 p.Article

Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndromeINOUE, Yuichi; HIRATA, Koichi; HAYASHIDA, Kenichi et al.Progress in neuro-psychopharmacology & biological psychiatry. 2013, Vol 40, pp 326-333, issn 0278-5846, 8 p.Article

Immunogenicity and tolerability of an investigational formulation of interferon-β1a : 24-and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase iiib study in adults with multiple sclerosisGIOVANNONI, Gavin; BARBARASH, Olga; CASSET-SEMANAZ, Florence et al.Clinical therapeutics. 2007, Vol 29, Num 6, pp 1128-1145, issn 0149-2918, 18 p.Article

The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis : CURRENT AND EMERGING THERAPIES FOR MULTIPLE SCLEROSISHUPPERTS, Raymond; GHAZI-VISSER, Lizette; SILVA, Ana Martins et al.Clinical therapeutics. 2014, Vol 36, Num 12, pp 1946-1957, issn 0149-2918, 12 p.Article

Tolerability and safety of novel half milliliter formulation of glatiramer acetate for subcutaneous injection: an open-label, multicenter, randomized comparative studyANDERSON, G; MEYER, D; HERRMAN, C. E et al.Journal of neurology. 2010, Vol 257, Num 11, pp 1917-1923, issn 0340-5354, 7 p.Article

A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-la (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosisMIKOL, D; LOPEZ-BRESNAHAN, M; TARASKIEWICZ, S et al.Multiple sclerosis. 2005, Vol 11, Num 5, pp 585-591, issn 1352-4585, 7 p.Article

Selective TNF-α inhibitor-induced injection site reactionsMURDACA, Giuseppe; SPANO, Francesca; PUPPO, Francesco et al.Expert opinion on drug safety. 2013, Vol 12, Num 2, pp 187-193, issn 1474-0338, 7 p.Article

  • Page / 1